Zobrazeno 1 - 10
of 76
pro vyhledávání: '"11"'
Autor:
Jeroen H. A. Creemers, Maarten J. van der Doelen, Sandra van Wilpe, Rick Hermsen, Tjitske Duiveman-de Boer, Diederik M. Somford, Marcel J. R. Janssen, J. P. Michiel Sedelaar, Niven Mehra, Johannes Textor, Harm Westdorp
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, 11, 1-10
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, 11, pp. 1-10
Frontiers in Oncology, 11, 1-10
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, 11, pp. 1-10
PurposeRadium-223 improves overall survival (OS) in men with bone metastatic castration-resistant prostate cancer (mCRPC). While the exact mechanism behind this survival benefit remains unclear, radium-induced immunological mechanisms might contribut
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Raskov, H, Orhan, A, Gaggar, S & Gögenur, I 2021, ' Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy ', Frontiers in Oncology, vol. 11, 668731 . https://doi.org/10.3389/fonc.2021.668731
Frontiers in Oncology, Vol 11 (2021)
Raskov, H, Orhan, A, Gaggar, S & Gögenur, I 2021, ' Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy ', Frontiers in Oncology, vol. 11, 668731 . https://doi.org/10.3389/fonc.2021.668731
Our understanding of the tumor microenvironment (TME), including the interplay between tumor cells, stromal cells, immune cells, and extracellular matrix components, is mandatory for the innovation of new therapeutic approaches in cancer. The cell-ce
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundFew studies have addressed the role of immune-related genes in the survival and prognosis of different esophageal cancer (EC) sub-types. We established two new prognostic model indexes by bioinformatics analysis to select patients with esop
Autor:
Kristoffer Staal Rohrberg, Vinicius Araujo Barbosa de Lima, Inge Marie Svane, Ulrik Lassen, Sine Reker Hadrup, Iben Spanggaard, Morten Hartvig Hansen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Araujo B. de Lima, V, Hansen, M, Spanggaard, I, Rohrberg, K, Reker Hadrup, S, Lassen, U & Svane, I M 2021, ' Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types ', Frontiers in Oncology, vol. 11, 558248 . https://doi.org/10.3389/fonc.2021.558248
Frontiers in Oncology
Araujo B. de Lima, V, Hansen, M, Spanggaard, I, Rohrberg, K, Reker Hadrup, S, Lassen, U & Svane, I M 2021, ' Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types ', Frontiers in Oncology, vol. 11, 558248 . https://doi.org/10.3389/fonc.2021.558248
Frontiers in Oncology
Despite encouraging results with immune checkpoint inhibition (ICI), a large fraction of cancer patients still does not achieve clinical benefit. Finding predictive markers in the complexity of the tumor microenvironment is a challenging task and oft
Autor:
Shiying Dang, Lin Chen, Xiao-Yong Zhan, Fei Yin, Ke Huang, Yun Li, Yang Kang, Yuhong Liang, Nan Wang, Tianshun Gao, Xing Xiao, Yi Zhang, Bihui Huang, Nannan Lai, Changfei Qin, Chuanming Luo, Yang Leng
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Lung cancer is one of the most common and mortal malignancies, usually with a poor prognosis in its advanced or recurrent stages. Recently, immune checkpoint inhibitors (ICIs) immunotherapy has revolutionized the treatment of human cancers including
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
The tumor microenvironment (TME) is a complex ecosystem comprised of cancer cells, stromal cells, and immune cells. Analysis of the composition of TME is essential to assess the prognosis of patients with breast cancer (BC) and the efficacy of differ
Autor:
Marta Truffi, Francesca Piccotti, Sara Albasini, Valentina Tibollo, Carlo Francesco Morasso, Federico Sottotetti, Fabio Corsi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
The host’s immune system plays a crucial role in determining the clinical outcome of many cancers, including breast cancer. Peripheral blood neutrophils and lymphocytes counts may be surrogate markers of systemic inflammation and potentially reflec
Autor:
Wen-Jie Luo, Dingwei Ye, Xiaoyan Dai, Yuan-Yuan Qu, Jin Wang, Wenjun Xiao, Yiping Zhu, Hailiang Zhang
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
ObjectiveThis study aimed to explore the role of ACSL4 in CD8+ T cell tumor infiltration and outcomes of bladder cancer (BLCA) patients after immunotherapy.MethodsThe correlation between ACSL4 expression and tumor infiltration of immune cells was ana
Autor:
Qingmei Deng, Hong Chen, Jingmiao Zhang, Fei Li, Xiaxia Zhu, Xiuxia Liu, Shan Huang, Xiaoxi Pang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundRecently, immune response modulation at epigenetic level is illustrated in studies, but it is still unclear about the possible function of RNA 5-methylcytosine (m5C) modification in the cell infiltration within tumor microenvironment (TME).
Autor:
Cristina Saiz-Ladera, Mariona Baliu-Piqué, Francisco J. Cimas, Aránzazu Manzano, Vanesa García-Barberán, Santiago Cabezas Camarero, Gonzalo Fernández Hinojal, Atanasio Pandiella, Balázs Győrffy, David Stewart, Juan J. Cruz-Hernández, Pedro Pérez-Segura, Alberto Ocana
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
instname
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
© 2021 Saiz-Ladera, Baliu-Piqué, Cimas, Manzano, García-Barberán, Camarero, Hinojal, Pandiella, Győrffy, Stewart, Cruz-Hernández, Pérez-Segura and Ocana.
Targeting the immune system has emerged as an effective therapeutic strategy for the
Targeting the immune system has emerged as an effective therapeutic strategy for the